BETHESDA, Md., Mar. 1, 2019 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the opening of
The move will better serve a growing membership throughout the Asia Pacific region and thriving chapters in Japan, Australia, Singapore, South Korea and Taiwan. With a permanent presence in Asia, PDA will increase the number of conferences and professional training offered to pharmaceutical professionals throughout the region. PDA expects to see membership there grow as well due to increased services.
"In accordance with PDA's Strategic Plan, PDA is proud to announce the establishment of PDA Asia Pacific," said Richard Johnson, PDA President & CEO. "Headquartered in Singapore, our team will help PDA expand our activities in this important region and support our members and chapters in the region. This will be a parallel organization to PDA Europe and PDA North America, and together with PDA Global Headquarters, will help us Connect People, Science and Regulation® across our community."
About PDA – Connecting People, Science and Regulation® The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
SOURCE Parenteral Drug Association
Subscribe to our Free Newsletters!